SDP4 Gene therapy

SDP4 –Opportunities and challenges for Sweden to become internationally leading in the field of gene therapy

Lead: Pfizer
Involved partners: Karolinska Cell Therapy Centre/SLL, GE Healthcare, RISE, Noricon, Recipharm, Combigene

This project aims to identify opportunities and challenges for Sweden to become internationally leading in the field of gene therapy. Face to face meetings and a workshop in November 2018 have been used to begin identifying key challenges and bottle necks (SWOT analyses) and suggest actionable recommendations which will lead to a final report and symposium in 2019.